Loading...
Header Logo
Keywords
Last Name
Institution

Search Results (34)

Click the Why column to see why an item matched the search.

MatchTypeWhy
Early pulmonary involvement in ankylosing spondylitis: assessment with thin-section CT.Academic Article Why?
Hemothorax--an unusual presentation of spinal fracture in ankylosing spondylitis.Academic Article Why?
Spondylitis, AnkylosingConcept Why?
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.Academic Article Why?
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.Academic Article Why?
An Atypical Presentation of a Thalamic Stroke in a Young Adult with Ankylosing Spondylitis and an Atrial Septal Defect.Academic Article Why?
Role of protein phosphatase magnesium-dependent 1A and anti-protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitis.Academic Article Why?
Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN).Academic Article Why?
Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.Academic Article Why?
Gravallese, EllenPerson Why?
The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.Academic Article Why?
Diagnostic Prevalence of Ankylosing Spondylitis Using Computerized Health Care Data, 1996 to 2009: Underrecognition in a US Health Care Setting.Academic Article Why?
Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.Academic Article Why?
Golimumab: A novel human anti-TNF-alpha monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis.Academic Article Why?
Patients' Concerns and Perceptions Regarding Biologic Therapies in Ankylosing Spondylitis: Insights from a Large-Scale Survey of Social Media Platforms.Academic Article Why?
Per Page    Page  of 3last Nextnext
Prev
Search Criteria
  • Ankylosing Spondylitis
Filter by Type